<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Bio Briefing - Countermeasures: General]]></title><link>http://www.upmc-biosecurity.org/</link><description><![CDATA[Biosecurity Briefing articles relating to general countermeasure developments.]]></description><copyright><![CDATA[Copyright 2010. University of Pittsburgh Medical Center. All rights reserved.]]></copyright><managingEditor><![CDATA[webmaster@umpc-biosecurity.org]]></managingEditor><webmaster><![CDATA[webmaster@umpc-biosecurity.org]]></webmaster><lastBuildDate>Mon, 04 Jan 2010 15:12:12 GMT</lastBuildDate><generator>SiteExecutive v4.1</generator><item><title><![CDATA[Draft of National Vaccine Plan Released (12-15-2008)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/govt_response/2008-12-15-draftnatlvacplan.html</link><description><![CDATA[Biosecurity Briefing: On December 4, 2008, HHS released a draft of its national vaccine strategy, a plan intended to guide the federal government in making policy decisions on vaccine development, production, and distribution.]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/govt_response/2008-12-15-draftnatlvacplan.html</guid><pubDate>Mon, 15 Dec 2008 21:27:15 GMT</pubDate></item><item><title><![CDATA[FDA Opening Offices Overseas to Address Food and Drug Safety (10-20-2008)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/countrmeasr_dev/2008/2008-10-20-fdaoverseas.html</link><description><![CDATA[Biosecurity Briefing: HHS announced plans to send U.S. Food and Drug Administration (FDA) staff to new offices in China, India, Europe, and Latin America as part of efforts to "enhance the safety of imported food and medical products."]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/countrmeasr_dev/2008/2008-10-20-fdaoverseas.html</guid><pubDate>Mon, 20 Oct 2008 21:17:30 GMT</pubDate></item><item><title><![CDATA[NIAID, BARDA Award Anthrax Vaccine Contracts, Ebola/Marburg Contracts (10-06-2008)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/countrmeasr_dev/2008/2008-10-06-niaidbardavaccontracts.html</link><description><![CDATA[Biosecurity Briefing: NIAID, BARDA awarded contracts to develop a next generation anthrax vaccine, as well as two contracts for development of a multivalent Ebola and Marburg vaccine.]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/countrmeasr_dev/2008/2008-10-06-niaidbardavaccontracts.html</guid><pubDate>Tue, 07 Oct 2008 16:55:10 GMT</pubDate></item><item><title><![CDATA[NIAID Awards Additional Funding for Smallpox Antiviral; DTRA Awards $8.3 Million for Research into Broad-Spectrum Antibiotics (09-29-2009)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/countrmeasr_dev/2008/2008-09-29-niaidfundsmallpxantiviral.html</link><description><![CDATA[Biosecurity Briefing: SIGA Tech. received an award from NIAID to accelerate development of its smallpox antiviral drug ST-246. SRI Intl announced DoD’s DTRA awarded contract to facilitate preclinical research in developing broad spectrum antibiotics.]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/countrmeasr_dev/2008/2008-09-29-niaidfundsmallpxantiviral.html</guid><pubDate>Mon, 29 Sep 2008 21:48:47 GMT</pubDate></item><item><title><![CDATA[DTRA Awards Contract to Study Potential of Cethromycin as Broad-Spectrum Antibiotic (08-18-2008)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/countrmeasr_dev/2008/2008-08-18-dtracontractcethromycin.html</link><description><![CDATA[Biosecurity Briefing: Advanced Life Sciences announced the award of a contract from the U.S. Dept of Defense Defense Threat Reduction Agency for advanced development of the antibiotic cethromycin as a potential broad-spectrum medical countermeasure.]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/countrmeasr_dev/2008/2008-08-18-dtracontractcethromycin.html</guid><pubDate>Mon, 18 Aug 2008 15:38:59 GMT</pubDate></item><item><title><![CDATA[Emergent BioSolutions Wins NIAID Grants, Sanofi to Acquire Acambis (08-04-2008)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/other/2008-08-04-emergentniaidsanofiacambis.html</link><description><![CDATA[Biosecurity Briefing: Emergent BioSolutions, Inc., announced it has been awarded two grants from NIAID for the development of botulism and next-generation anthrax vaccine candidates. AP reported that sanofi-aventis will acquire vaccine-maker Acambis PLC.]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/other/2008-08-04-emergentniaidsanofiacambis.html</guid><pubDate>Mon, 04 Aug 2008 17:15:47 GMT</pubDate></item><item><title><![CDATA[FDA Changes Process for Product Licensure Notification (07-11-2008)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/govt_response/2008-07-11-fdaproductlicensenotice.html</link><description><![CDATA[Biosecurity Briefing: The FDA issued a news release announcing a change in the format of letters that are sent to pharmaceutical companies to inform them of the FDA's decision regarding licensure of pharmaceutical products.]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/govt_response/2008-07-11-fdaproductlicensenotice.html</guid><pubDate>Mon, 14 Jul 2008 15:21:02 GMT</pubDate></item><item><title><![CDATA[Annual Report on Project BioShield Released to Congress (07-11-2008)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/countrmeasr_dev/2008/2008-07-11-annualrptbioshield.html</link><description><![CDATA[Biosecurity Briefing: HHS announced that the Annual Report to Congress on Project BioShield had been released. This Congressionally mandated report covers progress for the period from August 2006 through July 2007.]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/countrmeasr_dev/2008/2008-07-11-annualrptbioshield.html</guid><pubDate>Mon, 14 Jul 2008 14:38:25 GMT</pubDate></item><item><title><![CDATA[Cangene Delivers Botulism Antitoxin to SNS; DynPort, DoD Developing Plague Vaccine (06-13-2008)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/countrmeasr_dev/2008/2008-06-13-cangenebotulismantitox.html</link><description><![CDATA[Biosecurity Briefing: CNW reported that Canadian pharmaceutical company Cangene made a large delivery of botulism antitoxin (BAT) to the U.S. government, intended for integration into the U.S. Strategic National Stockpile (SNS).]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/countrmeasr_dev/2008/2008-06-13-cangenebotulismantitox.html</guid><pubDate>Fri, 13 Jun 2008 22:05:46 GMT</pubDate></item><item><title><![CDATA[HHS Announces Director for Biomedical Advanced Research Development Authority (BARDA) (04-18-2008)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/govt_response/2008-04-18-hhsannouncedirectorbarda.html</link><description><![CDATA[Biosecurity Briefing: On April 14, 2008, the U.S. Department of Health and Human Services (HHS) issued a press release naming Robin Robinson, Ph.D. as the first director of the Biomedical Advanced Research Development Authority (BARDA).]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/govt_response/2008-04-18-hhsannouncedirectorbarda.html</guid><pubDate>Fri, 18 Apr 2008 20:45:56 GMT</pubDate></item><item><title><![CDATA[Ebola Virus Made Safe to Work With in Laboratories (01-25-2008)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/vhf/2008-01-25-ebolasafelaboratories.html</link><description><![CDATA[Biosecurity Briefing: The Proceedings of the National Academy of Sciences (PNAS) published a study describing the generation of a new research strain of Ebola virus which would be "safe" to handle "outside of a biosafety level-4 facility."]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/vhf/2008-01-25-ebolasafelaboratories.html</guid><pubDate>Mon, 28 Jan 2008 15:56:30 GMT</pubDate></item><item><title><![CDATA[Lower Dose of Vaccine Administered to Broader Population May Reduce Total Number Infected in a Pandemic (06-29-2007)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/countrmeasr_dev/content/2007/2007-06-29-lowerdoseofvaccine.html</link><description><![CDATA[Biosecurity Briefing: A paper published PLoS Medicine suggests that infection rates during a flu pandemic could be reduced if more people were vaccinated with lower doses of vaccine rather than if a lesser number of people are vaccinated with full doses.]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/countrmeasr_dev/content/2007/2007-06-29-lowerdoseofvaccine.html</guid><pubDate>Tue, 03 Jul 2007 13:50:23 GMT</pubDate></item><item><title><![CDATA[Study Reveals Possibilities for New Botulism Treatments and Countermeasures (01-12-2007)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/content/botulism/2007-01-12-studyrevealspossibilitiesnewbotulismtreatments.html</link><description><![CDATA[Biosecurity Briefing: Dec. 21, 2006, study published in the journal Nature reveals new findings on the molecular mechanisms whereby botulinum neurotoxin, the causative agent of botulism, adheres to nerves and disrupts chemical signaling to muscles.]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/content/botulism/2007-01-12-studyrevealspossibilitiesnewbotulismtreatments.html</guid><pubDate>Fri, 12 Jan 2007 17:22:00 GMT</pubDate></item><item><title><![CDATA[HHS Buys Botulism Antitoxin for SNS (06-02-2006)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/content/botulism/2006-06-02-hhsantitoxin.html</link><description><![CDATA[Biosecurity Briefing: On June 1, HHS announced that it has awarded a 5-year, $362,641,105 contract to Cangene Corporation for the delivery of 200,000 doses of Heptavalent Botulism Antitoxin to the Strategic National Stockpile (SNS).]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/content/botulism/2006-06-02-hhsantitoxin.html</guid><pubDate>Fri, 02 Jun 2006 17:22:00 GMT</pubDate></item><item><title><![CDATA[Experimental Marburg Virus Vaccine May Confer Protection against Disease when Administered Post-Exposure (05-01-2006)]]></title><link>http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/content/viral_hemorrhagic_fevers/2006-05-01-experimentalmarburgvaxmayco.html</link><description><![CDATA[Biosecurity Briefing: A study published April 27 by the journal Lancet found that an experimental vaccine against Marburg haemorrhagic fever may protect against disease when administered after exposure to Marburg virus.]]></description><guid isPermaLink="true">http://www.upmc-biosecurity.org/website/biosecurity_briefing/archive/agents_diseases/content/viral_hemorrhagic_fevers/2006-05-01-experimentalmarburgvaxmayco.html</guid><pubDate>Mon, 01 May 2006 17:22:00 GMT</pubDate></item></channel></rss>
